Evaluating safety of phage therapy for bone and joint infections
Phage Safety Retrospective Cohort Study
This study is trying to see if phage therapy is safe for people with bone and joint infections by looking at any side effects they might have after treatment.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 25 (estimated) |
| Sex | All |
| Sponsor | Hospices Civils de Lyon Academic / other |
| Locations | 1 site (Lyon) |
| Trial ID | NCT04724603 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the relationship between adverse events and phage therapy in patients treated for bone, joint, or implant infections. By analyzing data from patients who experienced adverse effects after receiving phage therapy, the study seeks to determine whether these events are attributable to the therapy itself, surgical interventions, or antibiotic treatments. The findings could provide valuable insights into the safety profile of phage therapy in this context.
Who should consider this trial
Good fit: Ideal candidates are patients who have undergone phage therapy for bone, joint, or implant infections and experienced adverse events.
Not a fit: Patients who have not received phage therapy or those without adverse events related to their treatment may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the understanding of phage therapy safety, potentially leading to improved treatment protocols for bone and joint infections.
How similar studies have performed: While phage therapy is a novel approach, there is limited existing research specifically assessing its safety in the context of bone and joint infections, making this study relatively untested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * patients having had a bone or joint or implant infection treated by phagotherapy and having had an adverse event Exclusion Criteria: \-
Where this trial is running
Lyon
- Hospices Civils de Lyon — Lyon, France (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.